Clinical Trials for Flamingo Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Flamingo Therapeutics

Clinical Trials (2)

Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

PHASE1Recruiting

24 participants

Started: May 8, 2024 · Completed: Jul 31, 2028

3 conditions3 sponsors2 locations

Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

PHASE2Recruiting

81 participants

Started: May 30, 2023 · Completed: May 30, 2026

1 condition1 sponsor32 locations